Neuralink, the brain-technology company co-founded by Elon Musk, has announced the launch of the PRIME Study, a clinical trial for its fully implantable, wireless brain-computer interface. The trial aims to evaluate the safety of its N1 Implant and R1 surgical robot, while testing the ability of the BCI system to help individuals with quadriplegia control external devices like computers and …
It is impossible to ignore the allure of technology, particularly when it cohabits a sweet spot, intersecting with human health. The latest update on Elon Musk’s Neuralink to start human trials of brain implants for paralysis patients will sit squarely in that bracket. Two days after surgery, the man was cracking jokes and able to sit in a chair; the …
